Martin Treder

Founder at

LTZ Therapeutics, Inc.

Health Technology

Consumer Services

Commercial Services

Profile

Martin Treder was the founder of U3 Pharma AG, founded in 2001, serving as Research Director in 2002.
Dr. Treder was the founder of CT Atlantic Ltd., founded in 2008, serving as Chief Scientific Officer from 2008 to 2014.
Dr. Treder is the founder of LTZ Therapeutics, Inc., founded in 2021, serving as Chief Scientific Officer since 2021.
Dr. Treder is the founder of Shenzhen LTZ Therapeutics Co., Ltd., founded in 2022.
Dr. Treder was Chief Scientific Officer at Affimed NV from 2015 to 2019.
Dr. Treder completed undergraduate studies at Monash University and earned a doctorate from Technische Universität München.

Martin Treder active positions

Companies	Position	Start
LTZ Therapeutics, Inc. LTZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as immunotherapy-focused biotech company which develops novel therapies	Founder	2020-12-31

All active positions of Martin Treder

Former positions of Martin Treder

Companies	Position	End
AFFIMED N.V.	Chief Tech/Sci/R&D Officer	2019-05-21
CT Atlantic Ltd. CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development of human-derived antibodies for the treatment of cancer	Founder	2014-11-30
U3 Pharma AG U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment	Founder	2008-09-30
Shenzhen LTZ Therapeutics Co., Ltd. Shenzhen LTZ Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy drugs for cancer and complex diseases	Founder	-

See the detail of Martin Treder's experience

Training of Martin Treder

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Treder's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Affimed NV Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs	Health Technology
Monash University Monash University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technische Universität München Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
U3 Pharma AG U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment	Commercial Services
CT Atlantic Ltd. CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development of human-derived antibodies for the treatment of cancer	Commercial Services
LTZ Therapeutics, Inc. LTZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as immunotherapy-focused biotech company which develops novel therapies	Health Technology
Shenzhen LTZ Therapeutics Co., Ltd. Shenzhen LTZ Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy drugs for cancer and complex diseases	Health Technology